Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Intraocular Lymphoma × Phacoemulsification × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Presbyopia 1 Intraocular Lymphoma 1 Cataract 1

Interventions

Rituximab 14 Peripheral Blood Stem Cell Transplantation 12 Cyclophosphamide 12 fludarabine phosphate 10 Whole-Body Irradiation 8 Filgrastim 8 Cyclosporine 8 Mycophenolic Acid 7 Methotrexate 7 Etoposide 7 Lenalidomide 6 Tacrolimus 5 Radiotherapy 5 Dexamethasone 5 Cytarabine 5 Vorinostat 4 Therapeutics 4 Melphalan 4 Carboplatin 4 Antilymphocyte Serum 4 Thiotepa 3 Psychiatric Rehabilitation 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Flow Cytometry 3 Dasatinib 3 Busulfan 3 Bortezomib 3 tanespimycin 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07439835 2026-02-27

IOL-VAC

Democritus University of Thrace

Cataract, Presbyopia, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡